Shabir A. Madhi

6 ta ish

University of the Witwatersrand

1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

   Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi +97

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.554494

2. Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

   Shabir A. Madhi, Nigel A. Cunliffe, A. Duncan Steele +9

   MaqolaOAOchiq kirish20102 iqtibos

   ABIABI:AkademIndex/2026.other.146058

3. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study

   Katherine L. O’Brien, Henry C. Baggett, W. Abdullah Brooks +74

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.411034

4. A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV Infection

   Keith P. Klugman, Shabir A. Madhi, Robin Huebner +3

   Maqola20032 iqtibos

   ABIABI:AkademIndex/2026.other.489772

5. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

   Ting Shi, David McAllister, Katherine L. O’Brien +97

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.767352

6. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

   Elizabeth Harausz, Anthony J. Garcia‐Prats, Stephanie J. Law +47

   Sharh maqolaOAOchiq kirish20181 iqtibos

   ABIABI:AkademIndex/2026.other.135315